Literature DB >> 21486740

Reproducibility of segmentation error correction in age-related macular degeneration: Stratus versus Cirrus OCT.

Ilse Krebs1, Stefan Hagen, Eva Smretschnig, Irene Womastek, Werner Brannath, Susanne Binder.   

Abstract

INTRODUCTION: The accuracy of retinal thickness measurement in age-related macular degeneration by optical coherence tomography (OCT) is affected by threshold algorithm line errors. The reproducibility of error correction in Stratus and Cirrus OCT should be examined.
METHODS: OCT examinations of a consecutive series of 104 patients with neovascular age-related macular degeneration included in another study were reviewed. 72 eyes exhibited failures in Stratus OCT and 32 eyes in Cirrus OCT and were included in this new study. Algorithm line failures of Stratus OCT (retinal thickness program) and Cirrus OCT (Macular Cube 512×128 program) were corrected independently twice by two ophthalmologists and two residents, respectively, using the Stratus and Cirrus OCT built-in software. Reproducibility was assessed by the interclass correlation coefficient (ICC).
RESULTS: The corrected values of central retinal thickness were significantly lower than the automated measured values in Stratus OCT for all examiners (p<0.001), while in Cirrus OCT the differences were not significant (p=0.06-0.09). For Stratus OCT, the ICC for central retinal thickness was 0.991 and 0.997 for the experienced ophthalmologists and 0.89 and 0.97 for the residents. For Cirrus OCT, the ICC was 1.0 and 1.0 for the experienced ophthalmologists and 0.99 and 0.95 for the residents.
CONCLUSION: The reproducibility of threshold algorithm line failure correction was good overall in Stratus and Cirrus OCT and can therefore be recommended to improve retinal thickness measurement, particularly when experienced examiners perform the corrections.

Entities:  

Mesh:

Year:  2011        PMID: 21486740     DOI: 10.1136/bjo.2010.194662

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

Authors:  Meidong Zhu; Jamie K Chew; Geoffrey K Broadhead; Kehui Luo; Nichole Joachim; Thomas Hong; Adil Syed; Andrew A Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-10       Impact factor: 3.117

2.  Reliability and reproducibility of spectral and time domain optical coherence tomography images before and after correction for patients with age-related macular degeneration.

Authors:  Mohammad A Sadiq; Aymen Rashid; Roomasa Channa; Elham Hatef; Diana V Do; Quan Dong Nguyen; Yasir J Sepah
Journal:  F1000Res       Date:  2013-05-23

3.  Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease.

Authors:  Xiangrong Kong; Alexander Ho; Beatriz Munoz; Sheila West; Rupert W Strauss; Anamika Jha; Ann Ervin; Jeff Buzas; Mandeep Singh; Zhihong Hu; Janet Cheetham; Michael Ip; Hendrik P N Scholl
Journal:  Transl Vis Sci Technol       Date:  2019-06-21       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.